Loading...
Anti-AAV Antibodies in AAV Gene Therapy: Current Challenges and Possible Solutions
Adeno-associated virus (AAV) vector-based gene therapy is currently the only in vivo gene therapy approved in the US and Europe. The recent tragic death of three children in a clinical trial to treat X-Linked Myotubular Myopathy by delivering myotubularin with an AAV8 vector notwithstanding, AAV rem...
Na minha lista:
| Udgivet i: | Front Immunol |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8010240/ https://ncbi.nlm.nih.gov/pubmed/33815421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.658399 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|